Next Science Limited is a medical technology company headquartered in Sydney, Australia, with a research and development centre in Florida, USA. It is listed on the ASX under ASX Code ‘NXS’. Next Science’s primary focus is the development and continued commercialisation of its proprietary XbioTM technology to reduce the impact of biofilm based infections in human health.

Half Year & Full Year Reports

Period Ending Presentation Webcast Results Release
2019 Annual Report Opens in new window
2019 Full Year Results Opens in new window Opens in new window Opens in new window
2019 Half Year Results Opens in new window Opens in new window
2018 Full Year Results Opens in new window
2017 Full Year Results Opens in new window
2016 Full Year Results Opens in new window

Investor contacts

Investor queries

Next Science Limited
Level 19, Tower A, The Zenith
821 Pacific Highway, Chatswood
NSW 2067
Ph: +61 2 9375 7989
E: [email protected]

Share Registry queries

Link Market Services Limited
Level 12, 680 George Street
Sydney NSW 2000
Ph: 1300 554 474